ADHD,Adult ADHD,IN THE NEWS

No Cancer Risk with ADHD Meds

IN THE NEWS…

American Academy of Child and Adolescent Psychiatry, November 2008

Contrary to a previous concerns, new research shows ADHD medications don’t increase genetic damage and cancer risk.

A new study from Duke University Medical Center and the National Institutes of Health found that two popular medications for treating attention-deficit hyperactivity disorder (ADHD) — methylphenidate (Ritalin LA and Concerta) and amphetamine (Adderall and Adderall XR) — do not lead to an increased risk for developing cancer.

The study counters a previous one that reported an increase in genetic damage in children taking methylphenidate. The genetic damage is associated with an increased risk of cancer.

The new study used a larger sample of children, and did not find increased genetic abnormalities.

The study was published in the November online issue of the Journal of the American Academy of Child & Adolescent Psychiatry.

Read more about the study

Leave a Reply

WHY ARE WE DIFFERENT?

Most medical doctors who treat ADD/ADHD do so as part of a larger practice. ADHD Specialists focuses primarily on only treating ADD and related conditions. This intense focus allows us to continually sharpen our clinical skills, attend specialized training, utilize the latest therapies, and build our process to meet the specific needs of our clients.

Often medical, testing and counseling services are all separately owned and located practices. It just does not make sense to have to travel from one location to another to treat the same condition. Besides the issue of time and travel, how cohesive and effective is care being delivered in multiple locations by multiple, unrelated providers who don’t have time to talk to each other?

We Are Conveniently Located

in the Northern area of Los Angeles, the San Fernando Valley, in the City of Encino, near the 405 and 101 freeway interchange.
15720 Ventura Blvd. #503

Encino, CA 91436